Adenocarcinoma of the Pancreas Recruiting Phase 1 Trials for Ipilimumab (DB06186)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03373188VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerTreatment